ACE and cancer: Although cardioprotective medications such as beta‐blockers, statins, and angiotensin‐converting enzyme inhibitors (ACEI) may also help attenuate cardiotoxicity associated with cancer treatment [7], their use in cancer survivors is inconsistent, with both underutilisation and higher utilisation being reported [8, 9, 10].